MedWatch

Novo Nordisk chair believes in globalization despite international tensions

Helge Lund, chair of Novo Nordisk’s board of directors, says that although globalization has taken blows, the end goal is still mutually beneficial international trade. Among other tasks, large firms must now also secure supply chains to an extent not seen before.

Photo: Novo Nordisk / PR

The chair of Novo Nordisk’s board of directors, Helge Lund, shares his thoughts at the company’s annual general meeting, mentioning that it has never been as demanding to run a large business as it is today, as reported by Danish business daily Børsen.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs